References
- DugelPUBandelloFLoewensteinADexamethasone intravitreal implant in the treatment of diabetic macular edemaClin Ophthalmol20159 1321 133526213460
- YangYBaileyCLoewensteinAMassinPIntravitreal corticosteroids in diabetic macular edema: pharmacokinetic considerationsRetina20153512 2440 244926352555
- BezatisASpitalGHöhnFFunctional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up – the SOLO studyActa Ophthalmol2013915 e340 e34723638803
- CoscasGAugustinABandelloFRetreatment with Ozurdex for macular edema secondary to retinal vein occlusionEur J Ophthalmol2014241 1 924249150
- ChinHSParkTSMoonYSOhJHDifference in clearance of intravitreal triamcinolone acetonide between vitrectomized and non vitrectomized eyesRetina2005255 556 56016077349
- Chang-LinJEBurkeJAPengQPharmacokinetics of a sustained release dexamethasone intravitreal implant in vitrectomized and non vitrectomized eyesInvest Ophthalmol Vis Sci2011527 4605 460921421864
- ShaikhAHPetersenMRSiskRAFosterRERiemannCDMillerDMComparative effectiveness of the dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to central retinal vein occlusionOphthalmic Surg Lasers Imaging Retina2013441 28 3323418731
- AdanAPelegrínLReyADexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patientsRetina2013337 1435 144023514796
- HallerJABandelloFBelfortRJrOzurdex GENEVA Study GroupDexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsOphthalmology201111812 2453 246021764136
- BoyerDSYoonYHBelfortRJrOzurdex MEAD Study GroupThree-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edemaOphthalmology201412110 1904 191424907062
- RosenfeldPJBrownDMHeierJSMARINA Study GroupRanibizumab for neovascular age-related macular degenerationN Engl J Med200635514 1419 143117021318
- DingXPatelMChanCCMolecular pathology of age-related macular degenerationProg Retin Eye Res2009281 1 1819026761
- SpaideRFRationale for combination therapy in age-related macular degenerationRetina200929Suppl 6 S5 S719553803
- AdamisAPThe rationale for drug combinations in age-related macular degenerationRetina200929Suppl 6 S42 S4419553800
- CouchSMBakriSJReview of combination therapies for neovascular age-related macular degenerationSemin Ophthalmol2011263 114 12021609223
- DasRARomanoAChiosiFCombined treatment modalities for age related macular degenerationCurr Drug Targets2011122 182 18920887244
- KvantaAAlgverePVBerglinLSubfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factorInvest Ophthalmol Vis Sci1996379 1929 19348759365
- Gallego-PinazoRMarín-LambíesCMarín-OlmosFIntravitreal dexamethasone as an enhancer for the anti-VEGF treatment in neovascular ARMD: recovering an old allyArch Soc Esp Oftalmol2010852 79 8020566180
- ThompsonJTCataract formation and other complications of intravitreal triamcinolone for macular edemaAm J Ophthalmol20061414 629 63716564796
- RothDBVermaVRealiniTPrennerJLFeuerWJFechtnerRDLong-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injectionOphthalmology20091163 455 46019157561
- RanchodTMRaySKDanielsSALeongCJTingTDVerneAZLuce-Dex: a prospective study comparing ranibizumab plus dexamethasone combination therapy versus ranibizumab monotherapy for neovascular age-related macular degenerationRetina2013338 1600 160423549100
- CalvoPFerrerasAAl AdelFWangYBrentMHDexamethasone intravitreal as adjunct therapy for patients with wet age-related macular degeneration with incomplete response to ranibizumabBr J Ophthalmol2015996 723 72625425713
- KuppermannBDGoldsteinMMaturiRKOzurdex® ERIE Study GroupDexamethasone intravitreal implant as adjunctive therapy to ranibizumab in neovascular age-related macular degeneration: a multicenter randomized controlled trialOphthalmologica20152341 40 5426088793
- Rezar-DreindlSEibenbergerKBuehlWRole of additional dexamethasone for the management of persistent or recurrent neovascular age-related macular degeneration under ranibizumab treatmentRetina2017375 962 97027575409
- ChaudharyVBarbosaJLamWCOzurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study)Can J Ophthalmol2016514 302 30527521672
- ShelstaHNJampolLMPharmacologic therapy of pseudophakic cystoid macular edema: 2010 updateRetina2011311 4 1221187730
- SivaprasadSBunceCWormlandRNon-steroidal anti-inflammatory agents for cystoid macular edema following cataract surgery: a systematic reviewBr J Ophthalmol20058911 1420 142216234444
- CatierATadayoniRMassinPGaudricAAdvantages of acetazolamide associated with anti-inflammatory medications in postoperative treatment of macular edemaJ Fr Ophtalmol20052810 1027 103116395193
- SpitzerMSZiemssenFYoeruekEPetermeierKAisenbreySSzurmanPEfficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edemaJ Cataract Refract Surg2008341 70 7518165084
- DeuterCMGeliskenFStübigerNZierhutMDoychevaDSuccessful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three casesOcul Immunol Inflamm2011193 216 21821595541
- WuLArevaloJFHernandez-BogantesERocaJAIntravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study GroupInt Ophthalmol2012323 235 24322484726
- ThachABDugelPUFlindallRJA comparison of retrobulbar versus sub-Tenon’s corticosteroid therapy for cystoid macular edema refractory to topical medicationsOphthalmology199710412 2003 20089400758
- WilliamsGAHallerJAKuppermannBDDexamethasone DDS Phase II Study Group. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndromeAm J Ophthalmol20091476 1048 105419268890
- MeyerLMSchönfeldCLCystoid macular edema after complicated cataract surgery resolved by an intravitreal dexamethasone 0.7-mg implantCase Rep Ophthalmol201123 319 32222125533
- Dutra MedeirosMNavarroRGarcia-ArumíJMateoCCorcósteguiBDexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndromeInvest Ophthalmol Vis Sci2013545 3320 332423599334
- BrynskovTLaugesenCSHalborgJKempHSørensenTLLongstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implantsClin Ophthalmol20137 1171 117423818753
- FeniciaVBalestrieriMPerdicchiAMauriziEnriciMDelleFaveMRecuperoSMIntravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of Irvine-Gass syndromeCase Rep Ophthalmol201452 243 24825232337
- DangYMuYLiLComparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patientsDrug Des Devel Ther20148 1441 1449
- FurinoCBosciaFRecchimurzoNSborgiaCAlessioGIntravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsificationEur J Ophthalmol2014243 387 39124170523
- Al ZamilWMShort-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edemaSaudi J Ophthalmol2015292 130 13425892932
- KhuranaRNPalmerJDPorcoTCWielandMRDexamethasone intravitreal implant for pseudophakic cystoid macular edema in patients with diabetesOphthalmic Surg Lasers Imaging Retina2015461 56 6125559510
- Ortega-EvangelioLDiago SempereTStudy of the effect of intravitreal dexamethasone implant in pseudophakic macular edema. PreliminaryArch Soc Esp Oftalmol2015907 303 30725817965
- MylonasGGeorgopoulosMMalamosPMacula Study Group ViennaComparison of dexamethasone intravitreal implant with conventional triamcinolone in patients with postoperative cystoid macular edemaCurr Eye Res20169 1 5
- BellocqDPierre-KahnVMatontiFEffectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 studyBr J Ophthalmol2017101 333 341
- SacchiMVillaniEGilardoniFNucciPEfficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literatureClin Ophthalmol20148 1253 125725061272
- TurellMESinghADVascular tumors of the retina and choroid: diagnosis and treatmentMiddle East Afr J Ophthalmol2010173 191 20020844673
- YehSWilsonDJPars plana vitrectomy and endoresection of a retinal vasoproliferative tumorArch Ophthalmol20101289 1196 119920837805
- CebeciZOrayMTuncerSTugal TutkunIKirNIntravitreal dexamethasone implant (Ozurdex) and photodynamic therapy for vasoproliferative retinal tumoursCan J Ophthalmol2014494 e83 e8425103664
- YannuzziLAIBardalAMFreundKBChenKJEandiCMBlodiBIdiopathic macular telangiectasiaArch Ophthalmol20061244 450 46016606869
- ParkDWSchatzHMcDonaldHRJohnsonRNGrid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasisOphthalmology199710411 1838 18469373114
- De LahitteGDCohenSYGaudricALack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularizationAm J Ophthalmol20041385 892 89415531343
- TakayamaKIOotoSTamuraHIntravitreal bevacizumab for type 1 idiopathic macular telangiectasiaEye2010249 1492 149720431610
- TerauchiGMatsumotoCSShinodaKPars plana vitrectomy combined with focal endolaser photocoagulation for idiopathic macular telangiectasiaCase Rep Med20142014 78657824876845
- WuLEvansTArévaloJFLong-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasiaRetina2008282 314 31918301037
- SandaliOAkesbiJRodallecTLarocheLNordmannJPDexamethasone implant for the treatment of edema related to idiopathic macular telangiectasiaCan J Ophthalmol2013484 e78 e8023931489
- LoutfiMPapathomasTKamalAMacular oedema related to idiopathic macular telangiectasia type 1 treated with dexamethasone intravitreal implant (ozurdex)Case Rep Ophthalmol Med20142014 23191325045562
- SiglerEJRandolphJCCalzadaJIWilsonMWHaikBGCurrent management of Coats diseaseSurv Ophthalmol2014591 30 4624138893
- GhaziNGAl ShamsiHLarssonJAbboudEIntravitreal triamcinolone in Coats’ diseaseOphthalmology20121193 648 64922385486
- ChaudharyKMMititeluMLiebermanRMAn evidence-based review of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 2. Coats’ disease, Best disease, and uveitis with childhood neovascularizationJ Pediatr Ophthalmol Strabismus2013501 11 1922938515
- SaatciAODorukHCYamanAIntravitreal dexamethasone implant (ozurdex) in Coats’ diseaseCase Rep Ophthalmol201343 122 12824163679
- Martínez-CastilloSGallego-PinazoRDolz-MarcoRAdult Coats’ disease successfully managed with the dexamethasone intravitreal implant (ozurdex®) combined with retinal photocoagulationCase Rep Ophthalmol201231 123 12722548046
- LeiSLamWCEfficacy and safety of dexamethasone intravitreal implant for refractory macular edema in childrenCan J Ophthalmol2015503 236 24126040225
- BaillifSMaschiCGastaudPCaujolleJPIntravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanomaRetina2013339 1784 179023652581
- CaminalJMFlores-MorenoIAriasLIntravitreal dexamethasone implant for radiation maculopathy secondary to plaque brachytherapy in choroidal melanomaRetina2015359 1890 189726035401
- RussoAAvitabileTUvaMRadiation macular edema after Ru-106 plaque brachytherapy for choroidal melanoma resolved by an intravitreal dexamethasone 0.7-mg implantCase Rep Ophthalmol201231 71 7622529805
- BuiKMChowCCMielerWFTreatment of recalcitrant radiation maculopathy using intravitreal dexamethasone (Ozurdex) implantRetin Cases Brief Rep201483 167 17025372430
- SeibelIHagerARiechardtAIDavidsAMBökerAJoussenAMAntiangiogenic or corticosteroid treatment in patients with radiation maculopathy after proton beam therapy for uveal melanomaAm J Ophthalmol2016168 31 3927163234
- TarmannLLangmannGMayerCWegerMHaasAWack-ernagelWOzurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumabActa Ophthalmol2014928 694 696
- YoshidaNIkedaYNotomiSLaboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosaOphthalmology20131201 e5 e12
- HeckenlivelyJRJordanBLAptsiauriNAssociation of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosaAm J Ophthalmol19991275 565 57310334350
- CoxSNHayEBirdACTreatment of chronic macular edema with acetazolamideArch Ophthalmol19881069 1190 11953415543
- García-ArumíJMartinezVSararolsLCorcosteguiBVitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosaOphthalmology20031106 1164 116912799242
- YuzbasiogluEArtunayORasierRSengulABahceciogluHIntravitreal bevacizumab (Avastin) injection in retinitis pigmentosaCurr Eye Res2009343 231 23719274531
- SallumJMFarahMESaraivaVSTreatment of cystoid macular oedema related to retinitis pigmentosa with intravitreal triamcinolone acetonide: case reportAdv Exp Med Biol2003533 79 8115180250
- OzdemirHKaracorluMKaracorluSIntravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosaActa Ophthalmol Scand2005832 248 25115799743
- ScorolliLMoraraMMeduriATreatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinoloneArch Ophthalmol20071256 759 76417562986
- SrourMQuerquesGLevezielNIntravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosaGraefes Arch Clin Exp Ophthalmol20132516 1501 150623275039
- AhnSJKimKEWooSJParkKHThe effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature reviewOphthalmic Surg Lasers Imaging Retina2014452 160 16424506098
- SaatciAOSelverOBSeymenogluGYamanABilateral intravitreal dexamethasone implant for retinitis pigmentosa-related macular edemaCase Rep Ophthalmol201341 53 5823616764
- PatilLLoteryAJCoat’s-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implantEye (Lond)2014284 449 45124458202
- FurinoCBosciaFRecchimurzoNSborgiaCAlessioGIntravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular puckerRetina2014348 1612 161624752008
- TaneyLSBaumalCRDukerJSSustained-release dexamethasone intravitreal implant for persistent macular edema after vitrectomy for epiretinal membraneOphthalmic Surg Lasers Imaging Retina2015462 224 22825707048
- MerkoudisNGranstamETreatment of postoperative cystoid macular oedema with dexamethasone intravitreal implant in a vitrectomized eye – a case reportActa Ophthalmol2013913 238 239
- GeorgalasIPetrouPPapakonstantinouDDroumouchtsisVTservakisIPost-operative refractory cystoid macular edema in a vitrectomized eye treated with slow-release dexamethasone implant (Ozurdex)Cutan Ocul Toxicol2015343 257 25925198407
- BonfiglioVFallicoMRRussoAIntravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral bucklingEur J Ophthalmol2015255 e98 e10025790811
- HallerJABandelloFBelfortRJrDexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsOphthalmology201111812 2453 246021764136
- LowderCIBelfortRJrLightmanSDexamethasone intravitreal implant for noninfectious intermediate or posterior uveitisArch Ophthalmol20111295 545 55321220619